Entrada Therapeutics Statistics
Total Valuation
TRDA has a market cap or net worth of $322.06 million. The enterprise value is -$20.20 million.
Important Dates
The next estimated earnings date is Tuesday, May 6, 2025, before market open.
Earnings Date | May 6, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
TRDA has 35.63 million shares outstanding. The number of shares has increased by 18.01% in one year.
Current Share Class | 35.63M |
Shares Outstanding | 35.63M |
Shares Change (YoY) | +18.01% |
Shares Change (QoQ) | +5.96% |
Owned by Insiders (%) | 1.04% |
Owned by Institutions (%) | 52.93% |
Float | 19.03M |
Valuation Ratios
The trailing PE ratio is 5.38.
PE Ratio | 5.38 |
Forward PE | n/a |
PS Ratio | 1.69 |
Forward PS | 7.62 |
PB Ratio | 0.79 |
P/TBV Ratio | 0.79 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.15, with a Debt / Equity ratio of 0.14.
Current Ratio | 11.15 |
Quick Ratio | 10.78 |
Debt / Equity | 0.14 |
Debt / EBITDA | 0.92 |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 19.56% and return on invested capital (ROIC) is 7.36%.
Return on Equity (ROE) | 19.56% |
Return on Assets (ROA) | 5.90% |
Return on Invested Capital (ROIC) | 7.36% |
Return on Capital Employed (ROCE) | 9.66% |
Revenue Per Employee | $1.15M |
Profits Per Employee | $358,612 |
Employee Count | 183 |
Asset Turnover | 0.42 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, TRDA has paid $859,000 in taxes.
Income Tax | 859,000 |
Effective Tax Rate | 1.29% |
Stock Price Statistics
The stock price has decreased by -35.99% in the last 52 weeks. The beta is 0.02, so TRDA's price volatility has been lower than the market average.
Beta (5Y) | 0.02 |
52-Week Price Change | -35.99% |
50-Day Moving Average | 11.90 |
200-Day Moving Average | 15.47 |
Relative Strength Index (RSI) | 26.72 |
Average Volume (20 Days) | 87,561 |
Short Selling Information
The latest short interest is 1.23 million, so 3.46% of the outstanding shares have been sold short.
Short Interest | 1.23M |
Short Previous Month | 1.38M |
Short % of Shares Out | 3.46% |
Short % of Float | 6.48% |
Short Ratio (days to cover) | 9.77 |
Income Statement
In the last 12 months, TRDA had revenue of $210.78 million and earned $65.63 million in profits. Earnings per share was $1.68.
Revenue | 210.78M |
Gross Profit | 85.48M |
Operating Income | 47.01M |
Pretax Income | 40.51M |
Net Income | 65.63M |
EBITDA | 50.78M |
EBIT | 47.01M |
Earnings Per Share (EPS) | $1.68 |
Full Income Statement Balance Sheet
The company has $420.00 million in cash and $59.21 million in debt, giving a net cash position of $360.79 million or $10.13 per share.
Cash & Cash Equivalents | 420.00M |
Total Debt | 59.21M |
Net Cash | 360.79M |
Net Cash Per Share | $10.13 |
Equity (Book Value) | 428.68M |
Book Value Per Share | 12.04 |
Working Capital | 400.56M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$41.56 million and capital expenditures -$3.16 million, giving a free cash flow of -$44.72 million.
Operating Cash Flow | -41.56M |
Capital Expenditures | -3.16M |
Free Cash Flow | -44.72M |
FCF Per Share | -$1.26 |
Full Cash Flow Statement Margins
Gross margin is 40.55%, with operating and profit margins of 22.30% and 31.13%.
Gross Margin | 40.55% |
Operating Margin | 22.30% |
Pretax Margin | 31.54% |
Profit Margin | 31.13% |
EBITDA Margin | 24.09% |
EBIT Margin | 22.30% |
FCF Margin | n/a |
Dividends & Yields
TRDA does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -18.01% |
Shareholder Yield | n/a |
Earnings Yield | 19.27% |
FCF Yield | -13.13% |
Analyst Forecast
The average price target for TRDA is $25.67, which is 183.96% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $25.67 |
Price Target Difference | 183.96% |
Analyst Consensus | Strong Buy |
Analyst Count | 3 |
Revenue Growth Forecast (5Y) | -34.72% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
TRDA has an Altman Z-Score of 4.53 and a Piotroski F-Score of 5.
Altman Z-Score | 4.53 |
Piotroski F-Score | 5 |